SRPT

Sarepta Therapeutics Inc

• TipRanks·15h ago

  Sarepta price target raised to $19 from $18 at RBC Capital

• Simply Wall St·18h ago

  Is Sarepta Therapeutics (SRPT) Starting To Look Interesting Again After Recent Share Price Rebound

• Reuters·20h ago

  SAREPTA THERAPEUTICS INC <SRPT.O>: RBC RAISES TARGET PRICE TO $19 FROM $18

• Reuters·22h ago

  U.S. RESEARCH ROUNDUP-Centerspace, Union Pacific, XPO

• Simply Wall St·3d ago

  Sarepta Therapeutics (SRPT) Is Up 16.3% After Early siRNA Muscle Data Validates Avß6 Platform

• TipRanks·6d ago

  Wells Fargo Remains a Buy on Sarepta Therapeutics (SRPT)

• Reuters·03/31 20:06

  Sarepta grants 113,855 RSUs to 24 new hires under 2024 inducement plan

• Reuters·03/31 20:05

  SAREPTA THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

• Seeking Alpha·03/30 18:10

  Tango Therapeutics is the best performing healthcare stock in March

• Simply Wall St·03/30 08:09

  Assessing Sarepta Therapeutics (SRPT) Valuation After Recent Share Price Swings

• Benzinga·03/27 17:09

  Nasdaq 100 Enters Correction As 30-Year Yields Near 5%: What's Moving Markets Friday?

• NASDAQ·03/27 15:30

  Why Is Sarepta Therapeutics (SRPT) Up 24.2% Since Last Earnings Report?

• Simply Wall St·03/27 07:07

  Could Sarepta Therapeutics’ (SRPT) New siRNA Data Mark a Turning Point Beyond Duchenne Therapies?

• Seeking Alpha·03/26 20:27

  Wave Life Sciences: WVE-007 Data Leaves Biotech Shaken And Stirred (Downgrade)

• NASDAQ·03/26 17:14

  SRPT Stock Surges on Promising Early Results From siRNA Programs